Literature DB >> 2198086

Serum levels of IgE-binding factor (soluble CD23) in diseases associated with elevated IgE.

Y Yanagihara1, M Sarfati, D Marsh, T Nutman, G Delespesse.   

Abstract

Several in-vitro experiments suggest that the low affinity receptor for IgE (Fc epsilon RII) and its soluble fragment (IgE-binding factor, IgE-BF) are multi-functional molecules and more particularly that they are capable of regulating the synthesis of human IgE. In an attempt to examine the in-vivo significance of these in-vitro observations, the serum level of IgE-BF was measured in individuals with allergic or parasitic diseases, both associated with an increased production of IgE. IgE-BF was measured by a radioimmunoassay employing two mAbs against Fc epsilon RII (mAbER). We first compared 257 allergic subjects to 172 non-allergic controls matched for age and sex. Statistical analysis of the data, after logarithmic transformation of IgE-BF and IgE values, revealed that despite a great overlap, the allergic subjects had significantly higher levels of IgE-BF. The correlation between IgE and IgE-BF was very weak but significant. Allergic or non-allergic children had significantly higher IgE-BF levels than the corresponding groups of adults; moreover, the inverse correlation between age and IgE-BF levels was significant only in the children and not in the adults. The IgE-BF levels were not influenced by gender, by hyposensitization therapy or by treatment with local steroids. Subjects receiving systemic steroids had lower IgE-BF levels than untreated subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2198086     DOI: 10.1111/j.1365-2222.1990.tb02800.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  10 in total

1.  Elevated soluble CD23 levels in the sera from patients with localized scleroderma.

Authors:  S Sato; M Fujimoto; K Kikuchi; H Ihn; K Tamaki; K Takehara
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

Review 2.  CD23: novel disease marker with a split personality.

Authors:  J Gordon
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

3.  Soluble serum CD23 levels and CD23 molecule expression on intestinal epithelial cells in infants with reaginic and non reaginic cow's milk allergy.

Authors:  A Lachaux; I Grosjean; J Y Bonnefoy; D Kaiserlian
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

4.  Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus.

Authors:  A Bansal; T Roberts; E M Hay; R Kay; R S Pumphrey; P B Wilson
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

5.  Determination of soluble CD21 as a parameter of B cell activation.

Authors:  H P Huemer; C Larcher; W M Prodinger; A L Petzer; M Mitterer; N Falser
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

6.  Inhibition of sCD23 and immunoglobulin E release from human B cells by a metalloproteinase inhibitor, GI 129471.

Authors:  D J Wheeler; S Parveen; K Pollock; R J Williams
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

7.  Differences in IL-4 release by PBMC are related with heterogeneity of atopy.

Authors:  J Pène; A Rivier; B Lagier; W M Becker; F B Michel; J Bousquet
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

8.  Soluble CD23 controls IgE synthesis and homeostasis in human B cells.

Authors:  Alison M Cooper; Philip S Hobson; Mark R Jutton; Michael W Kao; Binia Drung; Boris Schmidt; David J Fear; Andrew J Beavil; James M McDonnell; Brian J Sutton; Hannah J Gould
Journal:  J Immunol       Date:  2012-03-05       Impact factor: 5.422

9.  A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases.

Authors:  C R Hewitt; A P Brown; B J Hart; D I Pritchard
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

10.  Serum levels of total IgE and soluble CD23 in bronchial asthma.

Authors:  G D Lorenzo; P Mansueto; M Melluso; G Morici; D Cigna; G Candore; C Caruso
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.